News Trials set up filings for AZ's triple therapy in asthma AstraZeneca's three-drug inhaler Breztri has shown efficacy for uncontrolled asthma in a pair of trials that could extend its label beyond COPD.
News Smart sensor cleared for use with AZ asthma, COPD inhalers A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers.